Astellas Pharma
ALPMY----
Forecast & RatingOnly 1 analyst currently covers Astellas Pharma (ALPMY.US), with a price target of $17.40 and a rating of "Buy". The sample is very small, so treat this as a reference only. Data as of Sep 8, 2026; this does not constitute investment advice.
Sep 8, 2026Price forecast
$17.409.99%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateNov 2, 2026
Forecast met53.4%
Stock price$15.82
Avg. target$14.7
High target$15
Low target$15
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.